These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7132302)

  • 21. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG vaccination protects against leprosy in Venezuela: a case-control study.
    Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to lepromin unaltered by application of zinc to the skin in lepromatous leprosy patients.
    Subramanyam VR
    Lepr Rev; 1986 Mar; 57(1):72-3. PubMed ID: 3702584
    [No Abstract]   [Full Text] [Related]  

  • 25. Note on some observations about the post-lepromin scar.
    Walter J; Tamondong CT; Garbajosa PG; Bechelli LM; Sansarricq H; Lwin K; Gyi MM
    Lepr Rev; 1977 Sep; 48(3):169-74. PubMed ID: 904423
    [No Abstract]   [Full Text] [Related]  

  • 26. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
    Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
    Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
    Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-vaccination sensitization with ICRC vaccine.
    Vallishayee RS; Gupte MD; Anantharaman DS; Nagaraju B
    Indian J Lepr; 1996; 68(2):167-74. PubMed ID: 8835586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Skin tests with histoplasmin, coccidioidin, sporotrichin and lepromin].
    Carrada Bravo T; Andrade A
    Salud Publica Mex; 1968; 10(2):173-94. PubMed ID: 5741445
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conditions of positive determination of Mitsuda's test].
    Campos NS
    Rev Bras Leprol; 1968-1969; 36(1):37-46. PubMed ID: 5748410
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Dharmendra antigen. (V) attempts for purification of specific skin delayed hypersensitivity (DH) inducing antigen (S) from lepromin.
    Sengupta U; Sinha S; Ramu G; Mukherjee A; Desikan KV
    Lepr India; 1982 Apr; 54(2):208-13. PubMed ID: 7132291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic factors and effect of BCG vaccination in the Mitsuda reaction].
    Beiguelman B; Souza-Campos N; Pinto W
    Rev Paul Med; 1967 Dec; 71(6):271-8. PubMed ID: 5620097
    [No Abstract]   [Full Text] [Related]  

  • 35. Corticosteroids and lepromin sensitivity.
    Kundu SK; Hazra SK; Ghosh S; Chaudhuri S
    Lepr India; 1982 Jul; 54(3):489-98. PubMed ID: 7176537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nature and familial character of lepromin sensitivity in 27 families and their siblings.
    Kundu SK; Ghosh S; Hazra SK; Chaudhury S
    Lepr India; 1979 Oct; 51(4):465-74. PubMed ID: 522440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of clinical, histological and immunological features across the leprosy spectrum.
    Narayan NP; Ramu G; Desikan KV; Vallishayee RS
    Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cell mediated immunity in healthy contacts of leprosy.
    Kurhade AM; Akulwar SL; Pathak AA; Thakar YS; Dhanvijay AG
    Indian J Pathol Microbiol; 1996 Jul; 39(3):197-201. PubMed ID: 8972148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological studies in children of a low-endemic region, a high-endemic region, and dwellers of a leprosy colony: evaluation of anti-ND-BSA antibodies and lepromin response.
    Shah DH; Vartak RR; Naik SS; Dandekar SR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):539-46. PubMed ID: 7868951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genesis of leprosy lesions.
    Ramu G
    Indian J Lepr; 1987; 59(2):133-44. PubMed ID: 3309083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.